Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma

Spassova, Ivelina; Ugurel, Selma; Kubat, Linda; Zimmer, Lisa; Terheyden, Patrick; Mohr, Annalena; Andtback, Hannah Bjorn; Villabona, Lisa; Leiter, Ulrike; Eigentler, Thomas; Loquai, Carmen; Hassel, Jessica C.; Gambichler, Thilo; Haferkamp, Sebastian; Mohr, Peter; Pfoehler, Claudia; Heinzerling, Lucie; Gutzmer, Ralf; Utikal, Jochen S.; Horny, Kai; Schildhaus, Hans-Ulrich; Habermann, Daniel; Hoffmann, Daniel; Schadendorf, Dirk; Becker, Juergen Christian

Clinical and molecular characteristics associated with response to therapeutic PD-1/PD-L1 inhibition in advanced Merkel cell carcinoma

Autor(en):

Spassova, Ivelina; Ugurel, Selma; Kubat, Linda; Zimmer, Lisa; Terheyden, Patrick; Mohr, Annalena; Andtback, Hannah Bjorn; Villabona, Lisa; Leiter, Ulrike; Eigentler, Thomas; Loquai, Carmen; Hassel, Jessica C.; Gambichler, Thilo; Haferkamp, Sebastian; Mohr, Peter; Pfoehler, Claudia; Heinzerling, Lucie; Gutzmer, Ralf; Utikal, Jochen S.; Horny, Kai; Schildhaus, Hans-Ulrich; Habermann, Daniel; Hoffmann, Daniel; Schadendorf, Dirk; Becker, Juergen Christian

Tübinger Autor(en):

Leiter, Ulrike
Eigentler, Thomas

Erschienen in:

Journal For Immunotherapy of Cancer (2022), Bd. 10, H. 1

Verlagsangabe:

Bmj Publishing Group

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1136/jitc-2021-003198

ISSN:

2051-1426